羟氯喹视网膜毒性筛查方法的研究进展

doi:10.3969/j.issn.1001-8131.2024.01.046

Abstract
Figure/Table
References
Related Citation (0)

Download: PDF (469 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Long-term excessive use of hydroxychloroquine (HCQ) can lead to retinal damage, a well-established ocular side effect that can cause severe and irreversible central vision loss in advanced stages. However, early lesions are usually asymptomatic and therefore difficult to detect. With the development of automated visual field and retinal technology, early lesions can be detected before significant visual impairment occurs. Therefore, sensitive and effective screening for early retinopathy is essential. This article will focus on reviewing the screening methods for retinal toxicity in HCQ in order to improve the understanding of retinal toxicity screening in HCQ.

Key words： hydroxychloroquine retinal toxicity hydroxychloroquine screening methods

Received: 27 December 2023

PACS:

R774.1

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Zhong Yongfang
	Wang Haibin

Cite this article:

Zhong Yongfang,Wang Haibin. Research Progress on the Screening Methods For Hydroxychloroquine Retinal Toxicity[J]. journal1, 2024, 44(1): 134-137.

URL:

http://www.hrbyybjb.org.cn/EN/10.3969/j.issn.1001-8131.2024.01.046 OR http://www.hrbyybjb.org.cn/EN/Y2024/V44/I1/134

[1] Ewald SE,Lee BL,Lau L,et al.The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor.Nature 2008;456(7222):658-662.
[2] Schrezenmeier E.,D?rner T.Mechanisms of action of hydroxychloroquine and chloroquine:implications for rheumatology.Nat Rev Rheumatol 2020;16(3):155-166.
[3] Abdulaziz N,Shah AR,McCune WJ.Hydroxychloroquine:balancing the need to maintain therapeutic levels with ocular safety:an update.Curr Opin Rheumatol 2018;30(3):249-255.
[4] Yusuf IH,Foot B,Galloway J,et al.The Royal College of Ophthalmologists recommendations on screening for hydroxychloroquine and chloroquine users in the United Kingdom:executive summary.Eye (Lond) 2018;32(7):1168-1173.
[5] Costedoat-Chalumeau N,Dunogué B,Leroux G,et al.A Critical Review of the Effects of Hydroxychloroquine and Chloroquine on the Eye.Clin Rev Allergy Immunol 2015;49(3):317-326.
[6] Marmor MF,Kellner U,Lai TY,et al.Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).Ophthalmology 2016;123(6):1386-1394.
[7] Podoleanu AG.Optical coherence tomography.J Microsc 2012;247(3):209-219.
[8] Chen E,Brown DM,Benz MS,et al.Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the "flying saucer" sign).Clin Ophthalmol 2010;4(1151-1158).
[9] Stepien KE,Han DP,Schell J,et al.Spectral-domain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision loss.Trans Am Ophthalmol Soc 2009;107(28-33).
[10] Marmor MF.Comparison of screening procedures in hydroxychloroquine toxicity.Arch Ophthalmol 2012;130(4):461-469.
[11] Mititelu M,Wong BJ,Brenner M,et al.Progression of hydroxychloroquine toxic effects after drug therapy cessation:new evidence from multimodal imaging.JAMA Ophthalmol 2013;131(9):1187-1197.
[12] Kellner U,Renner AB,Tillack H.Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine.Invest Ophthalmol Vis Sci 2006;47(8):3531-3538.
[13] Farrell DF.Retinal toxicity to antimalarial drugs:chloroquine and hydroxychloroquine:a neurophysiologic study.Clin Ophthalmol 2012;6(377-383).
[14] Lyons JS,Severns ML.Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography.Am J Ophthalmol 2007;143(5):801-809.
[15] Ding HJ,Denniston AK,Rao VK,et al.Hydroxychloroquine-related retinal toxicity.Rheumatology (Oxford) 2016;55(6):957-967.
[16] Melles RB,Marmor MF.The Prevalence of Hydroxychloroquine Retinopathy and Toxic Dosing,and the Role of the Ophthalmologist in Reducing Both.Am J Ophthalmol 2016;170(240).
[17] Jia Y.,Tan O.,Tokayer J.,et al.Split-spectrum amplitude-decorrelation angiography with optical coherence tomography.Opt Express 2012;20(4):4710-4725.
[18] Huang Y.,Zhang Q.,Thorell M.R.,et al.Swept-source OCT angiography of the retinal vasculature using intensity differentiation-based optical microangiography algorithms.Ophthalmic Surg Lasers Imaging Retina 2014;45(5):382-389.
[19] Casado A,López-de-Eguileta A,Fonseca S,,et al.Outer Nuclear Layer Damage for Detection of Early Retinal Toxicity of Hydroxychloroquine.Biomedicines.Outer Nuclear Layer Damage for Detection of Early Retinal Toxicity of Hydroxychloroquine.Biomedicines2020;8(3):10.3390/biomedicines8030054]
[20] Bulut M,Ak?dan M,G?zkaya O,et al.Optical coherence tomography angiography for screening of hydroxychloroquine-induced retinal alterations.Graefes Arch Clin Exp Ophthalmol 2018;256(11):2075-2081.
[21] De Oliveira PR,Berger AR,Chow DR.Optical coherence tomography angiography in chorioretinal disorders.Can J Ophthalmol 2017;52(1):125-136.
[22] Sauer L,Calvo CM,Vitale AS,et al.Imaging of Hydroxychloroquine Toxicity with Fluorescence Lifetime Imaging Ophthalmoscopy.Ophthalmol Retina 2019;3(10):814-825.
[23] Solberg Y,Dysli C,M?ller B,et al.Fluorescence Lifetimes in Patients With Hydroxychloroquine Retinopathy.Invest Ophthalmol Vis Sci 2019;60(6):2165-2172.
[24] Yusuf IH,Charbel Issa P,Ahn SJ.Novel imaging techniques for hydroxychloroquine retinopathy.Front Med (Lausanne) 2022;9(1026934.
[25] Melles RB,Marmor MF.The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy.JAMA Ophthalmol 2014;132(12):1453-1460.
[26] Jaumouillé S,Espargillière D,Mouriaux F,et al.[Clinical evaluation of the new screening procedures for hydroxychloroquine retinopathy,according to the American Academy of Ophthalmology guidelines.Prospective study of 184 patients].J Fr Ophtalmol 2015;38(5):377-387.
[27] Yates M,Malaiya R,Stack J,et al.Hydroxychloroquine use:the potential impact of new ocular screening guidelines.Eye (Lond) 2018;32(1):161-162.
[28] Gobbett A,Kotagiri A,Bracewell C,et al.Two years' experience of screening for hydroxychloroquine retinopathy.Eye (Lond) 2021;35(4):1171-1177.
[29] Ahn SJ,Lee SU,Lee SH,,et al.Evaluation of Retromode Imaging for Use in Hydroxychloroquine Retinopathy.Am J Ophthalmol.Evaluation of Retromode Imaging for Use in Hydroxychloroquine Retinopathy.Am J Ophthalmol2018;196(44-52.
[30] Lee WJ,Lee BR,Shin YU.Retromode imaging:Review and perspectives.Saudi J Ophthalmol 2014;28(2):88-94.
[31] Keilhauer CN,Delori FC.Near-infrared autofluorescence imaging of the fundus:visualization of ocular melanin.Invest Ophthalmol Vis Sci 2006;47(8):3556-3564.
[32] Jauregui R,Park K.S,Duong JK,et al.Quantitative Comparison of Near-infrared Versus Short-wave Autofluorescence Imaging in Monitoring Progression of Retinitis Pigmentosa.Am J Ophthalmol 2018;194(120-125).
[33] Pfau M,Jolly J.K,Wu Z,et al.Fundus-controlled perimetry(microperimetry):Application as outcome measure in clinical trials.Prog Retin Eye Res 2021;82.
[34] Jivrajka RV,Genead MA,McAnany JJ,et al.Microperimetric sensitivity in patients on hydroxychloroquine (Plaquenil)therapy.Eye(Lond)2013;27(9):1044-1052.
[35] Martínez-Costa L,Victoria Iba?ez M,Murcia-Bello C,et al.Use of microperimetry to evaluate hydroxychloroquine and chloroquine retinal toxicity.Can J Ophthalmol 2013;48(5):400-405.
[36] Iftikhar M,Kaur R,Nefalar A,et al.MICROPERIMETRY AS A SCREENING TEST FOR HYDROXYCHLOROQUINE RETINOPATHY:The Hard-Risk-1 Study.Retina 2019;39(3):485-491.